FindTrial
Sign In

Clinical study and recurrent mechanism of MOG-IgG associated disorders in children in some areas of China

Clinical study and recurrent mechanism of MOG-IgG associated disorders in children in some areas of China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059995
Enrollment
Unknown
Registered
2022-05-14
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MOG-IgG associated disorders

Interventions

Case group:None

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The onset age is less than 18 years; 2. Meet the MOGAD diagnostic criteria in The Chinese Expert Consensus on the Diagnosis and Treatment of MOG-IgG associated disorders; 3. Signed informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 2.Demyelinating lesions secondary to infection, tumor and genetic metabolic diseases.

Design outcomes

Primary

MeasureTime frame
MOG-IgG;—

Countries

China

Contacts

Public ContactXinjie Liu

Qilu Hospital of Shandong University

liuxinjie-ert@163.com+86 18560086300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026